Examples of using Unacceptable toxicity in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
In clinical trials, treatment with Erivedge was continued until disease progression or until unacceptable toxicity.
In clinical trials, treatment with Odomzo was continued until disease progression or until unacceptable toxicity.
Treatment should be continued as long as clinical benefit is observed or until unacceptable toxicity develops.
It is recommended that treatment be continued until disease progression or until unacceptable toxicity has occurred.
It is recommended that treatment be continued until progression of the underlying disease or until unacceptable toxicity.
Treatment should continue as long as benefit is observed or until unacceptable toxicity occurs see section 4.4.
The recommended dose is 80 mg osimertinib once a day until disease progression or unacceptable toxicity.
It is recommended that treatment be continued until disease progression or unacceptable toxicity see section 5.1, study MO22224.
Kyprolis treatment was administered for a maximum of 18 cycles unless discontinued early for disease progression or unacceptable toxicity.
Treatment should continue until the patient no longer derives benefit or the development of unacceptable toxicity see Table 2.
Treatment with vemurafenib should continue until disease progression or the development of unacceptable toxicity see tables 1 and 2 below.
It is recommended that treatment be continued until progression of the underlying disease or until unacceptable toxicity see section 5.1.
In the Avastin-containing arms, patients could receive Avastin as a single-agent every 3 weeks until disease progression or unacceptable toxicity.
disease progression or unacceptable toxicity.
was discontinued early for disease progression or unacceptable toxicity.
It is recommended that patients continue treatment with trametinib until patients no longer derive benefit or the development of unacceptable toxicity.
Treatment with Cotellic should continue until the patient no longer derives benefit or until the development of unacceptable toxicity see Table 1 below.
Patients may continue therapy with nintedanib after discontinuation of docetaxel for as long as clinical benefit is observed or until unacceptable toxicity occurs.
placebo in combination with BR until disease progression, or unacceptable toxicity.
deterioration in performance status) or unacceptable toxicity.